These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1461089)

  • 1. MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T.
    Place DA; Faustino PJ; Berghmans KK; van Zijl PC; Chesnick AS; Cohen JS
    Magn Reson Imaging; 1992; 10(6):919-28. PubMed ID: 1461089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.
    Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE
    Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-selective contrast enhancing agent, Mn(III)meso- [tri(4-sulfonatophenyl)phenyl]porphine (MnTPPS3).
    Fiel R; Mark E; Button T; Gilani S; Musser D
    Magn Reson Imaging; 1993; 11(7):1079-81. PubMed ID: 8231675
    [No Abstract]   [Full Text] [Related]  

  • 4. Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imaging.
    van Zijl PC; Place DA; Cohen JS; Faustino PJ; Lyon RC; Patronas NJ
    Acta Radiol Suppl; 1990; 374():75-9. PubMed ID: 1966973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
    Furmanski P; Longley C
    Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloporphyrins as contrast agents for tumors in magnetic resonance imaging.
    Place DA; Faustino PJ; van Zijl PC; Chesnick A; Cohen JS
    Invest Radiol; 1990 Sep; 25 Suppl 1():S69-70. PubMed ID: 2283262
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue distribution and stability of metalloporphyrin MRI contrast agents.
    Lyon RC; Faustino PJ; Cohen JS; Katz A; Mornex F; Colcher D; Baglin C; Koenig SH; Hambright P
    Magn Reson Med; 1987 Jan; 4(1):24-33. PubMed ID: 3821476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.
    Fiel RJ; Musser DA; Mark EH; Mazurchuk R; Alletto JJ
    Magn Reson Imaging; 1990; 8(3):255-9. PubMed ID: 2366638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of human colon cancer xenograft with gadolinium-texaphyrin.
    Young SW; Fan Q
    Invest Radiol; 1996 May; 31(5):280-3. PubMed ID: 8724126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro and in vivo evaluation of manganese(III) porphyrin-dextran as a novel MRI contrast agent.
    Zhang Z; He R; Yan K; Guo QN; Lu YG; Wang XX; Lei H; Li ZY
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6675-8. PubMed ID: 19850475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of manganese and iron tetraphenylporphine sulfonates to albumin is relevant to their contrast properties.
    Yushmanov VE; Tominaga TT; Borissevitch IE; Imasato H; Tabak M
    Magn Reson Imaging; 1996; 14(3):255-61. PubMed ID: 8725191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese(iii)-chelated porphyrin microbubbles for enhanced ultrasound/MR bimodal tumor imaging through ultrasound-mediated micro-to-nano conversion.
    Chen M; Liang X; Dai Z
    Nanoscale; 2019 May; 11(21):10178-10182. PubMed ID: 31111845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manganese-enhanced MRI of minimally gadolinium-enhancing breast tumors.
    Ganesh T; Mokhtari RB; Alhamami M; Yeger H; Cheng HL
    J Magn Reson Imaging; 2015 Mar; 41(3):806-13. PubMed ID: 24591227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits].
    Kim SW; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour enhancement with newly developed Mn-metalloporphyrin (HOP-9P) in magnetic resonance imaging of mice.
    Takehara Y; Sakahara H; Masunaga H; Isogai S; Kodaira N; Takeda H; Saga T; Nakajima S; Sakata I
    Br J Cancer; 2001 Jun; 84(12):1681-5. PubMed ID: 11401324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor enhancement effect of overexpressed manganese-superoxide dismutase in manganese-enhanced MR imaging.
    Hasegawa S; Saito S; Koshikawa-Yano M; Furukawa T; Aoki I; Saga T
    Magn Reson Med Sci; 2011; 10(3):155-8. PubMed ID: 21959997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.